Citigroup »

Akebia Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $379k 306k 1.24
2023-09-30 $174k 153k 1.14
2023-03-31 $26 49 0.55
2022-12-31 $418 726 0.58
2022-09-30 $15k 47k 0.32
2021-12-31 $2.1M 926k 2.26
2021-03-31 $3.8M 1.1M 3.38
2020-12-31 $123k 44k 2.81
2020-09-30 $39k 16k 2.52
2020-06-30 $8.3M 608k 13.58
2020-03-31 $746k 98k 7.60
2019-12-31 $466k 74k 6.31
2019-09-30 $1.3M 330k 3.92
2019-06-30 $1.7M 349k 4.84
2019-03-31 $457k 56k 8.18
2018-12-31 $1.8M 316k 5.54
2018-09-30 $455k 52k 8.83
2018-06-30 $443k 45k 9.97
2018-03-31 $342k 36k 9.54
2017-12-31 $629k 42k 14.87
2017-09-30 $537k 27k 19.68
2017-06-30 $57k 4.0k 14.32
2017-03-31 $3.0k 322 9.32
2016-12-31 $94k 9.1k 10.37
2016-09-30 $0 25 0.00
2016-06-30 $61k 8.1k 7.51
2015-12-31 $121k 9.4k 12.93
2015-09-30 $5.3k 710 7.46
2015-06-30 $42k 4.0k 10.42
2014-09-30 $6.2k 282 21.98